Stay updated on Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Sign up to get notified when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.

Latest updates to the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 is now displayed. The earlier v3.4.1 notice about government funding and operating status has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a notice about a lapse in government funding, indicating information may not be up to date and directing users to opm.gov. Updated the page with Revision: v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedNon-significant changes include a 'Show glossary' toggle, capitalization tweaks to labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data), and a revision update from v3.3.4 to v3.4.0, which are cosmetic and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page footer now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check64 days agoChange DetectedHong Kong SAR is added as a study location under Locations (revision v3.3.3).SummaryDifference0.2%

- Check85 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the page (shown in the site header/footer). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.